113 related articles for article (PubMed ID: 1934301)
1. Sister chromatid exchange frequency in Hodgkin's disease patients with elevated in vivo hprt mutant frequencies.
Caggana M; Kelsey KT
Carcinogenesis; 1991 Nov; 12(11):2141-5. PubMed ID: 1934301
[TBL] [Abstract][Full Text] [Related]
2. In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients.
Caggana M; Liber HL; Mauch PM; Coleman CN; Kelsey KT
Environ Mol Mutagen; 1991; 18(1):6-13. PubMed ID: 1713845
[TBL] [Abstract][Full Text] [Related]
3. Variation of SCE frequency in lymphocyte cultures from patients with Hodgkin's disease before, during, and after treatment.
Brown T; Dawson AA; King DJ; Bullock I; Watt JL
Cancer Genet Cytogenet; 1986 Feb; 20(1-2):53-61. PubMed ID: 3753659
[TBL] [Abstract][Full Text] [Related]
4. A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Liang JC; Bailey NM; Gabriel GJ; Kattan MW; Wang RY; Hagemeister FB; Cabanillas FF; Fuller LM
Leuk Lymphoma; 1993 Apr; 9(6):503-8. PubMed ID: 7687918
[TBL] [Abstract][Full Text] [Related]
5. Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
Sen P; Bailey NM; Hagemeister FB; Liang JC
Cancer Res; 1990 Feb; 50(3):558-62. PubMed ID: 1688733
[TBL] [Abstract][Full Text] [Related]
6. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
[TBL] [Abstract][Full Text] [Related]
7. Sister chromatid exchange in malignant lymphomas.
Slavutsky I; de Vinuesa ML; Larripa I; de Pargament MM; de Salum SB
Cancer Genet Cytogenet; 1984 Oct; 13(2):153-8. PubMed ID: 6478441
[TBL] [Abstract][Full Text] [Related]
8. Sister chromatid exchange studies for monitoring DNA damage in lymphocytes of malignant lymphoma patients under cytostatic therapy.
Sardaş S; Erdoğan F; Sardaş OS; Cengel M; Karakaya AE
Anticancer Drugs; 1994 Aug; 5(4):487-9. PubMed ID: 7524801
[TBL] [Abstract][Full Text] [Related]
9. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
10. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
[No Abstract] [Full Text] [Related]
11. [Hodgkin's disease in children; treatment results with or without radiotherapy].
Behrendt H
Ned Tijdschr Geneeskd; 1986 May; 130(19):865-8. PubMed ID: 3754935
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of patients with Hodgkin's disease].
Onoshi T
Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):912-6. PubMed ID: 7964042
[No Abstract] [Full Text] [Related]
13. [Treatment of Hodgkin's disease including the staging laparotomy].
Yosida T; Nakanisi J; Kobayasi S; Ohtake S; Ito K; Nakamura S; Hattori K; Saito Y; Tanimoto K
Rinsho Ketsueki; 1984 Jun; 25(6):827-34. PubMed ID: 6548266
[No Abstract] [Full Text] [Related]
14. Combined-modality therapy for the treatment of Hodgkin's disease.
Hoppe RT
Front Radiat Ther Oncol; 1992; 26():172-80. PubMed ID: 1511919
[No Abstract] [Full Text] [Related]
15. [Term pregnancy in a patient with Hodgkin's disease subjected to multi-chemotherapy treatment combined with radiotherapy (description of a typical case)].
Migliavacca A; Petrocchi L; Perego C
Ann Ostet Ginecol Med Perinat; 1986; 107(5):290-5. PubMed ID: 3827074
[No Abstract] [Full Text] [Related]
16. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.
Schellong G; Pötter R; Brämswig J; Wagner W; Prott FJ; Dörffel W; Körholz D; Mann G; Rath B; Reiter A; Weissbach G; Riepenhausen M; Thiemann M; Schwarze EW
J Clin Oncol; 1999 Dec; 17(12):3736-44. PubMed ID: 10577845
[TBL] [Abstract][Full Text] [Related]
17. Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.
Yelle L; Bergsagel D; Basco V; Brown T; Bush R; Gillies J; Israels L; Miller A; Rideout D; Whitelaw D
J Clin Oncol; 1991 Nov; 9(11):1983-93. PubMed ID: 1941057
[TBL] [Abstract][Full Text] [Related]
18. [Hodgkin's lymphoma in children: results of treatment with the MOPP protocol and a combination of radiotherapy and chemotherapy].
Vuković I; Janković MB; Janić D; Stojimirović E
Srp Arh Celok Lek; 1985; 113(11-12):1013-21. PubMed ID: 3841764
[No Abstract] [Full Text] [Related]
19. Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
Prosnitz LR; Farber LR; Kapp DS; Scott J; Bertino JR; Fischer JJ; Cadman EC
J Clin Oncol; 1988 Apr; 6(4):603-12. PubMed ID: 2451712
[TBL] [Abstract][Full Text] [Related]
20. [Hodgkin's disease. Study of 100 cases].
Sans-Sabrafen J; Pedro Olivé C; Buxó Costa J; Pardo Peret P; Rodríguez Ferrera JC; Woessner S; Galofré M; Rodríguez Méndez F
Med Clin (Barc); 1987 Feb; 88(5):175-8. PubMed ID: 3561046
[No Abstract] [Full Text] [Related]
[Next] [New Search]
